On #NationalSTEMDay, we’re celebrating the power of curiosity and innovation. For generations, our researchers have dared to ask bold questions, push boundaries and turn ideas into breakthroughs aimed at saving and improving lives around the world. Discover more: http://merck.us/4hJ8UON
About us
At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.merck.com. This site is intended for residents of the United States and Canada and their territories only. FLS: http://merck.us/3TKXNuZ
- Website
-
http://merck.us/2J2xAUh
External link for Merck
- Industry
- Pharmaceutical Manufacturing
- Company size
- 10,001+ employees
- Headquarters
- Rahway, New Jersey
- Type
- Public Company
- Specialties
- Pharmaceutical
Locations
-
Primary
Get directions
126 E Lincoln Ave
P.O. Box 2000
Rahway, New Jersey 07065, US
-
Get directions
351 N Sumneytown Pike
North Wales, PA 19454, US
Employees at Merck
Updates
-
We're excited to share new data from our cardiovascular pipeline at #AHA25, including clinical trial results in hypercholesterolemia. Hear from some of our leaders on how we’re working to advance research to help address the CV epidemic and cardiovascular care by engaging with physicians, researchers and patient advocates. http://merck.us/3Lv3Npp
-
We have a long history of turning scientific discoveries into medicines that have changed the outlook of cardiovascular (CV) disease. At #AHA25, we’ll share the latest research from our CV pipeline. Learn more: http://merck.us/3JJz7Ai
-
High LDL cholesterol (“bad cholesterol”) typically presents no signs or symptoms, but plaques can silently build up in arteries over time, which may increase the risk of a heart attack or stroke. We are excited to share our latest research with the scientific community at #AHA25. Learn more: http://merck.us/47FqFtH
-
By exploring new approaches, our scientists hope to help patients diagnosed with certain retinal conditions like diabetic macular edema (DME). Learn more: http://merck.us/4oR8fgB #DiabeticEyeDiseaseMonth
-
-
Not too big. Not too small. Because of their intermediate size, macrocyclic peptides combine the potency and precise targeting of an antibody or biologic therapy with the stability and ease-of-administration of a pill. Swipe through to learn more. http://merck.us/3LuHxfn #DrawnToScience
-
Today, we announced a strategic funding agreement with Blackstone, positioning our company to advance development of an investigational antibody-drug conjugate targeting TROP2 while we continue to advance our broad and expansive pipeline. Read more: http://merck.us/4nGnqZh
-
Join us today at 9 a.m. ET to learn more about our Q3 2025 #earnings: http://merck.us/4nv9Kjx
-
Our Q3 2025 #earnings results are live. Check out our full MRK financial summary and key highlights: http://merck.us/4nqAul9
-
Today, we announced the European Commission’s approval of a new treatment option for certain patients with head and neck squamous cell carcinoma. Read more here: http://merck.us/3L9ncfD